Anna Lokshin, Ph.D., is a tenured Professor in the Department of Medicine, Division of Hematology Oncology at the University of Pittsburgh. Dr. Lokshin also serves as Director of Luminex Core Facility of University of Pittsburgh Cancer Institute. Dr. Lokshin’s research is focused on cancer biomarkers for screening, diagnosis, and prognosis, with particular emphasis on biomarkers of ovarian and pancreatic cancers. Dr. Lokshin’s studies will allow generation of multi biomarker-based algorithms allowing early detection of these cancers at the time when surgical intervention is curative. She has contributed over 100 publications to the scientific literature. She has served on several review and editorial boards and is a long standing member of the NCI Early Detection Research Network (EDRN). Dr. Lokshin earned her PhD in Genetics from the Leningrad University in Russia. She subsequently obtained postdoctoral training in cancer biology at the University of Pittsburgh.